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We report the case of a 16-year-old boy presented with a mild akinetic-rigid parkinsonism
shortly after a post-streptococcal infection. After stopping corticoids, he had a rapid
neurological deterioration to a fatal encephalitis lethargica-like syndrome. Serum analysis
demonstrated consistently elevated anti-streptolysin-O. This case illustrates a new severe
phenotype in the spectrum of the post-streptococcal disorders. This etiology should be
considered in the differential diagnosis of a movement disorder with a rapid detrimental
evolution.
& 2007 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.1. Introduction
Group A streptococcal infection is associated with autoim-
mune neuropsychiatric symptoms, typically with a relapsing-
remitting course, possibly mediated by antibodies against
basal ganglia neurons.1
We describe a boy who presented a mild parkinsonism and
who after stopping corticoids had a dramatic evolution to an
akinetic-mutism state associated with an inflammatory CSF
and widespread brain lesions. Although ds-DNA was mildly
positive, the diagnosis of systemic lupus erythematosus was
considered less probable inasmuch as the antinuclear and
anti-ENA antibodies were negative, complement levels were
normal and no other clinical or laboratorial criteria was
present.an Paediatric Neurology S
.
Beleza).2. Case report
A 16-year-old right-handed boy presented with left akinetic-
rigid parkinsonism 2 weeks after complete recovery of an
episode of pharingitis. His medical history was remarkable for
bilateral knee arthralgias, recurrent amygdalitis and in-
creased ASO titers since 9 years of age.
The imaging and laboratory study, performed 2 months
after the clinical onset, was normal except for the finding of
high ASO titers (245mL/mL; normalo200mL/mL). The work-up
included brain CT and MRI, hemogram, renal, hepatic and
thyroid functions, urinary and serum copper, ceruloplasmin,
erythrocyte sedimentation rate (ESR), ANA, ANCA, lupus
anticoagulant, anticardiolipin antibodies, circulant immuno-
complexes and urinary sediment.ociety. Published by Elsevier Ltd. All rights reserved.
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showing mild clinical improvement after trihexifenidil 2mg
tid and also when piribedil 50mg tid was added.
Afterwards, he presented a progressive clinical deteriora-
tion, with increasing rigidity and bradykinesia predominantly
in the left limbs. He was then provided levodopa/carbidopa
25/100mg tid and hydrocortisone 150mg IV on alternate days
replacing the previous drugs. This resulted in a clear clinical
improvement. He took hydrocortisone for 24 days. Four days
after stopping it, and despite still taking levodopa/carbidopa
25/100mg tid, he presented a rapidly progressive neurological
deterioration consisting of auditory allucinations, speech and
gait slowness and frequent falls. He progressed within 6 days
to an akinetic-mutism state with somnolence, generalized
limb and nuchal rigidity, left limbs dystonia and hyperther-
mia as was seen on the day he was admitted in the
Emergency Room (ER).
In the blood study, we underline hemoglobin of 8.9 g/dL
with a normal peripheral smear and negative Combs test. ESR
was increased (112mm/h; normal o20mm/h) as was creati-
nine kinase (CK) (810 IU/L; normal 40–175 IU/L), and C-reactive
protein (CRP) was normal. CSF study revealed 60 cells/mL (85%
lymphocytes), 0.51 g/dL proteins, normal glycorraquia and
negative viruses PCR for Measles, Herpes Simplex, Varicela
Zoster, Herpes 6, CMV, EBV and Enterovirus. Serum (Measles,
VDRL, HIV, HBV, HCV, CMV, EBV), metabolic (lactate, pyruvateFig. 1 – (A and B) Fluid-attenuated inversion-recovery (FLAIR)
images performed on day 5 show bilateral cortico-
subcortical high signal intensity lesions, with right
predominance. The left insula and putamen are involved.
(C and D) Brain CT performed on day 32 reveals extensive
bilateral hypodensity, and brain edema, with effacement of
the basal cisterns and surface sulci.and molecular study) and microbiological studies in the CSF
and blood were all negatives. Immunological study showed
high ASO titer of 1280mL/mL on day 4 and 1300mL/mL on day
11 showing the consistency of the finding. Hep-2 ANA, Anti
Sm, Anti-RNP, Anti-SSA, Anti-SSB, C3, C4, CH50 and immune
complexes were all normal or negative and ELISA ds-DNA,
42.1mL/min (normal o5mg/mL). Brain CT and MRI showed
extensive lesions, involving cortical and subcortical regions
bilaterally, left insula and putamen (Fig. 1A and B). EEG
showed a theta stupor (5Hz) without periodic activity.
He was then treated with methylprednisolone 1g IV id for 5
days, acyclovir 10mg/kg IV q8h for 14 days, cefotaxime 2g IV
q4h for 12 days and levodopa/carbidopa up to 125mg tid.
During the first 2 weeks, he showed no clinical improvement,
keeping the hyperthermia. On day 33, his neurological
condition worsened presenting brainstem dysfunction signs
and CT scan showed bilateral hypodensity and brain edema
(Fig. 1C and D). Then methylprednisolone cycle combined
with cyclophosphamide was initiated. However, unfortu-
nately he died 2 days later.3. Discussion
We describe a 16-year-old-boy who developed a progressive
neurological disease following a pharingitis. Starting with an
assymetric parkinsonism, he had a catastophic evolution
after corticoid suspension. This suggested the inflammatory
nature of the disease which was further corroborated by the
laboratory data. Actually, the blood investigation disclosed
high ESR level with normal PCR and the infectious and
metabolic studies performed on CSF and blood were all
normal.
His past medical history of bilateral arthralgias, the
occurrence of neurological deterioration with psychosis and
the high serum ds-DNA raised the hypothesis of systemic
lupus erythematosus (SLE). Children with SLE have a more
severe disease onset than adults2 and fever is a common early
manifestation.3 In fact, juvenile parkinsonism (mainly the
rigid-akinetic form), despite rare and not included in the 19
neuropsychiatric syndromes defined by the American College
of the Reumatology (ACR),4 is a known manifestation of SLE.5
In our patient, however, there was no clear evidence that
arthralgias were due to arthritis, the psychotic episode was
associated with a severe neurological involvement, and the
anemia was not hemolytic. Thus, none of these three findings
should be considered as diagnostic criteria of SLE according to
the ACR.6 In addition, the ds-DNA was only mildly positive
and was combined with consistent negative antinuclear and anti-
ENA antibodies, and also normal complement levels. Some studies
claim that ANA-negative Lupus in the Hep-2 cell era is
exceptionally rare.7 Other diagnostic criteria for SLE have
been suggested8 although they are less commonly applied.
A post-streptococcal disorder was considered as a diagnosis
of exclusion and was based on the past medical history of
recurrent amigdalitis with increased ASO titers, the onset of
parkinsonism 2 weeks after a pharingitis and the highly
increased ASO titers related to the neurological deterioration.
This diagnosis was further supported by the clinical, labora-
tory and imaging findings.
ARTICLE IN PRESS
E U RO P E A N J O U RNA L O F PA E D I AT R I C N E U RO L O G Y 12 ( 2008 ) 505 – 507 507Although rarely, parkinsonism may be the unique manifes-
tation of a post-streptococcal disorder.9 Moreover, the final
clinical, laboratory and imaging findings in our patient parallel
the encephalitis lethargica syndrome which is proved to be
related to basal ganglia autoimmunity.10 Accordingly, the
clinical picture that was seen consisted of somnolence,
lethargy, parkinsonism and mutism. The CSF showed hyper-
proteinorrachia and lymphocytic pleocytosis and the MRI
revealed high signal lesions on T2 involving the basal ganglia
and other cortico-subcortical areas. Although it is currently
hypothesized that an autoimmune process is the underlying
pathophysiological mechanism in post-streptococcal disor-
ders, specific disease related brain autoantigens have not been
identified.11 Thus, anti-basal antibodies should not be used yet
for diagnostic purposes.12 Our patient fits the original descrip-
tion of von Economo Encephalitis. Actually, the clinical onset
may well correspond to the less common ‘‘amyostatic-
akinetic’’ form and the last clinical picture to the ‘‘somno-
lent-ophthalmoplegic’’ form of this disease. Also, the clinical
evolution seen in this patient is in accordance with the
knowledge of von Economo. Hewrote in 1929 that a recurrence
of this disease would result in the somnolent-ophthalmoplegic
form, which was frequently fatal.13 In the literature we have
found only two patients9,10 presenting parkinsonism as a
manifestation of a post-streptococcal disorder but a relapse to
an encephalitis lethargica syndrome was not yet described.
In summary, the peculiarity of this case is the presentation
by discrete parkinsonian syndrome, which was followed by
an acute and catastrophic phase of a lethargic encephalitic
syndrome, possibly precipitated by a new streptococcus
infection and facilitated by the suspension of corticoids. This
represents a new severe phenotype that should be added to
the spectrum of post-streptococcal disorders, an etiology that
should be considered in a movement disorder with a rapid
detrimental evolution.
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